The Latest Breaking News from FDA

Two panels that advise the Food and Drug Administration are recommending that naloxone nasal spray be approved for over-the-counter sale for emergency treatment of opioid overdoses. The Joint Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee voted unanimously to approve the measure. The FDA will…

The biotech industry is well-positioned to witness significant growth on the backs of soaring demands and government spending. Moreover, given the sector’s defensive nature, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and United Therapeutics Corp. (UTHR) might be solid buys in 2023 that could help you set for life.…

When the U.S. Supreme Court overturned Roe v. Wade last year, freeing states to limit or ban abortion, we knew abortion pills would become a target.

A government document obtained by The Associated Press outlines more than three dozen cases in Liberia where it appears logs were illegally cut or moved out of the country using unofficial channels

Frappuccino not sold in stores but distributed in supermarkets by PepsiCo recalled after glass detected in 13.7oz bottles

The U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation

January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…

For those aspiring to eat mainly "clean ingredients," a little chemistry knowledge is often useful for deciphering packaged food labels.

The bottles of Starbucks' vanilla Frappuccinos may contain pieces of glass, the Food and Drug Administration said.

The author of "We the Scientists" explains how a group of parents facing the worst shook up medical research

Advisers to the FDA put the opioid overdose-reversal drug a step closer to being sold without a needing a prescription. Even if approved, the medication may not reach many people who need it.